These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 149152)

  • 1. Immune complexes in the rheumatic diseases.
    McDuffie FC
    J Allergy Clin Immunol; 1978 Jul; 62(1):37-43. PubMed ID: 149152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum complement and synovial complement. Respective variations in rheumatic pathology].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jun; 1(26):1769-76. PubMed ID: 4538278
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on immune complexes in rheumatoid arthritis.
    Bozsóky S; Merétey K; Falus A
    Ann Immunol Hung; 1979; 19():117-35. PubMed ID: 399579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complement activity in the serum and synovial fluid of various rheumatoid diseases].
    Richter H; Thumb N; Gangl A; Zilcher H; Hornich R
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:106-10. PubMed ID: 4538173
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical applications of complement measurements in rheumatic diseases.
    Goldstein IM
    Am J Med Sci; 1975; 269(2):172-82. PubMed ID: 1096603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of cold- and warm-reacting cytotoxins against lymphocytes, granulocytes, and monocytes in rheumatic diseases.
    Pruzanski W; Armstrong M; Urowitz MB
    Clin Immunol Immunopathol; 1978 Oct; 11(2):142-56. PubMed ID: 737913
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.
    Cats A; Lafeber GJ; Klein F
    Ann Rheum Dis; 1975 Apr; 34(2):146-55. PubMed ID: 806270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.
    Winchester RJ; Kunkel HG; Agnello V
    J Exp Med; 1971 Sep; 134(3 Pt 2):286s-295s. PubMed ID: 4998932
    [No Abstract]   [Full Text] [Related]  

  • 9. Leucocyte-specific anti-nuclear factors in patients with felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases.
    Faber V; Elling P
    Acta Med Scand; 1966 Mar; 179(3):257-67. PubMed ID: 5325973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibronectin and immune complexes in rheumatic diseases].
    Mazepa MA
    Vestn Akad Med Nauk SSSR; 1991; (4):57-61. PubMed ID: 1830993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of reduced complement level in the articular fluid. 81 cases].
    Del Pino Montes J; Meyer O; Borda Iriarte O; Belenguer Prieto R; Peltier AP; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):19-21. PubMed ID: 6601817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human complement by immunoglobulin G antigranulocyte antibody.
    Rustagi PK; Currie MS; Logue GL
    J Clin Invest; 1982 Dec; 70(6):1137-47. PubMed ID: 7174786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon in synovial fluid and serum of patients with rheumatic disease.
    Cesario TC; Andrews BS; Martin DA; Jason M; Treadwell T; Friou G; Tilles JG
    J Rheumatol; 1983 Aug; 10(4):647-50. PubMed ID: 6194296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune complexes in the pathogenesis of rheumatoid arthritis].
    Lavrova TR
    Ter Arkh; 1978; 50(10):125-31. PubMed ID: 81534
    [No Abstract]   [Full Text] [Related]  

  • 16. Appraisal of rheumatoid arthritis as an immune complex disease.
    Broder I; Urowitz MB; Gordon DA
    Med Clin North Am; 1972 Mar; 56(2):529-39. PubMed ID: 4111877
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum and synovial fluid activin A and inhibin A in some rheumatic diseases.
    El-Gendi SS; Moniem AE; Tawfik NM; Ashmawy MM; Mohammed OA; Mostafa AK; Zakhari MM; Herdan OM
    Int J Rheum Dis; 2010 Aug; 13(3):273-9. PubMed ID: 20704626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complexes in man: detection and clinical significance.
    McDougal JS; McDuffie FC
    Adv Clin Chem; 1985; 24():1-60. PubMed ID: 2936066
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and pathogenetic patterns in chronic rheumatic inflammation].
    Nasonova VA
    Vestn Akad Med Nauk SSSR; 1979; (12):3-12. PubMed ID: 316238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.